Warfarin

An anti-coagulant differs from (&minus)-warfarin by being five times less potent as a vitamin K antagonist has a longer terminal elimination half-life (35-58 hours) than (&minus)-warfarin (24-33 hours).

An anti-coagulant differs from (&minus)-warfarin by being five times less potent as a vitamin K antagonist has a longer terminal elimination half-life (35-58 hours) than (&minus)-warfarin (24-33 hours).

An anti-coagulant differs from (&minus)-warfarin by being five times less potent as a vitamin K antagonist has a longer terminal elimination half-life (35-58 hours) than (&minus)-warfarin (24-33 hours).

An anticoagulant differs from (+)-warfarin by being five times more potent as a vitamin K antagonist has a shorter terminal elimination half-life (24-33 hours) than (+)-warfarin (35-58 hours).

An anticoagulant differs from (+)-warfarin by being five times more potent as a vitamin K antagonist has a shorter terminal elimination half-life (24-33 hours) than (+)-warfarin (35-58 hours).

An anticoagulant differs from (+)-warfarin by being five times more potent as a vitamin K antagonist has a shorter terminal elimination half-life (24-33 hours) than (+)-warfarin (35-58 hours).

An anticoagulant differs from (+)-warfarin by being five times more potent as a vitamin K antagonist has a shorter terminal elimination half-life (24-33 hours) than (+)-warfarin (35-58 hours).

A racemic mixture of two optically active isomers, the R and S forms has a half-life of 36-42 hours in circulation, bound to plasma proteins, and accumulates in the liver, where the two isomers are metabolized by different pathways also used as a

This Material can be used for the metabolic assays of (S)-warfarin.

This Material can be used for the metabolic assays of (S)-warfarin.

This Material can be used for the metabolic assays of (S)-warfarin.

Application 7-Hydroxywarfarin can be used for the metabolic assays of (S)-warfarin. Biochem/physiol Actions CYP2C9 metabolite of (S)-warfarin.